Cas:54127-63-8 5-Chloro-6-hydroxynicotinic acid manufacturer & supplier

We serve Chemical Name:5-Chloro-6-hydroxynicotinic acid CAS:54127-63-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Chloro-6-hydroxynicotinic acid

Chemical Name:5-Chloro-6-hydroxynicotinic acid
CAS.NO:54127-63-8
Synonyms:5-Chloro-6-oxo-1,6-dihydro-3-pyridinecarboxylic acid;5-chloro-6-hydroxypyridine-3-carboxylic acid;5-Chloro-6-hydroxy-3-pyridinecarboxylic Acid;3-Pyridinecarboxylic acid, 5-chloro-6-hydroxy-;5-Chloro-6-hydroxynicotinic acid;5-chloro-6-oxo-1H-pyridine-3-carboxylic acid;MFCD00052950
Molecular Formula:C6H4ClNO3
Molecular Weight:173.554
HS Code:2933399090

Physical and Chemical Properties:
Melting point:≥300 °C(lit.)
Boiling point:437.3±45.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.640
PSA:70.42000
Exact Mass:172.987976
LogP:0.25

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Chloro-6-oxo-1,6-dihydro-3-pyridinecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00052950 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyridinecarboxylic acid, 5-chloro-6-hydroxy- Use and application,5-Chloro-6-oxo-1,6-dihydro-3-pyridinecarboxylic acid technical grade,usp/ep/jp grade.


Related News: Throughout the pandemic, our site remained fully operational while keeping our employees safe and having a positive impact on human health. Our expanded facility will provide us with the increased capacity needed to continue the essential services we provide to our clients” Toyocamycin manufacturers Just weeks ago, Orchard touted research in The New England Journal of Medicine supporting the use of the therapy. The study included 30 patients treated with OTL-101 and found that all of them were still alive after two years. 1-(2-phenylethyl)pyrrolidin-2-one suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2-(4-methoxycarbonylphenyl)ethanesulfonic acid vendor & factory.